Survival of the fittest or best adapted: HLA-dependent tumor development
AbstractThe major histocompatibility complex (MHC) comprises a set of genes that are critical to immunity and surveillance against neoplastic transformation. There is increasing evidence that the MHC antigens not only regulate antitumor immune responses in experimental animal models but directly correlate with survival and prognosis of patients with diverse types of cancers. MHC antigens may in the future function as potential biomarkers for prognosis and allow selection of cancer patients for intensive therapy.
- Abstract views: 1384
- PDF: 452
- HTML: 3317
Copyright (c) 2010 Giuseppe V. Masucci, Emilia Andersson, Lisa Villabona, Hildur Helgadottir, Kjell Bergfeldt, Federica Cavallo, Guido Forni, Soldano Ferrone, Aniruddha Choudhury, Barbara Seliger, Rolf Kiessling
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.